Clinical and Molecular Hepatology

Clinical and Molecular Hepatology is an internationally recognized, peer-reviewed, open-access journal published quarterly in English. Its mission is to disseminate cutting-edge knowledge, trends, and insights into hepatobiliary diseases, fostering an inclusive academic platform for robust debate and discussion among clinical practitioners, translational researchers, and basic scientists. With a multidisciplinary approach, the journal strives to enhance public health, particularly in the resource-limited Asia-Pacific region, which faces significant challenges such as high prevalence of B viral infection and hepatocellular carcinoma. Furthermore, Clinical and Molecular Hepatology prioritizes epidemiological studies of hepatobiliary diseases across diverse regions including East Asia, North Asia, Southeast Asia, Central Asia, South Asia, Southwest Asia, Pacific, Africa, Central Europe, Eastern Europe, Central America, and South America. The journal publishes a wide range of content, including original research papers, meta-analyses, letters to the editor, case reports, reviews, guidelines, editorials, and liver images and pathology, encompassing all facets of hepatology.

《Clinical and Molecular Hepatology》是一本国际公认的、经过同行评审的开放获取期刊，每年发行4期。其宗旨是传播肝胆疾病的前沿知识、趋势和见解，为临床医生、转化研究人员和基础科学家之间的激烈辩论和讨论建立一个包容性的学术平台。该期刊采用多学科方法，致力于增强公共卫生，特别是在资源有限的亚太地区，该地区面临着 B 病毒感染和肝细胞癌高发等重大挑战。此外，《Clinical and Molecular Hepatology》优先考虑不同地区的肝胆疾病的流行病学研究，包括东亚、北亚、东南亚、中亚、南亚、西南亚、太平洋、非洲、中欧、东欧、中美洲和南美洲。 该期刊发表内容广泛，包括原创研究论文、荟萃分析、致编辑的信、病例报告、评论、指南、社论以及肝脏图像和病理学，涵盖肝病学的各个方面。